Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
contextflow’s AI-powered software has demonstrated a reduction of average reading time by up to 31% for radiologists using the system, with a trend toward improved diagnostic accuracy. The company’s products are CE marked and used across Europe with ongoing proof-of-concept partnerships. Preliminary results are positive; full study results pending publication. The company has received significant funding from the European Innovation Council Accelerator program. Product features include nodule detection/tracking, quantitative/qualitative pattern analysis, reference case retrieval, and differential diagnosis support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on contextflow.